Business and Finance Business and Finance
Thu, January 23, 2025

Johnson & Johnson (NYSE:JNJ) Q4 2024 Earnings Call Transcript


Published on 2025-01-23 09:00:54 - MSN
  Print publication without navigation

  • Q4 2024 Earnings Call Transcript January 22, 2025 Johnson & Johnson beats earnings expectations. Reported EPS is $2.04, expectations were $1.99. Operator: Good morning and welcome to Johnson & Johnson's Fourth Quarter 2024 Earnings Conference Call.

The article provides a transcript of Johnson & Johnson's Q4 2024 earnings call, where the company discussed its financial performance for the last quarter of 2024. Key points include a detailed review of their financial results, with a focus on the growth in their pharmaceutical and medical device sectors. The CEO highlighted the successful launch of new products, strategic acquisitions, and the impact of ongoing legal issues, particularly related to talc litigation. The call also covered forward-looking statements about expected revenue growth, cost-saving initiatives, and the company's strategy to navigate through economic challenges and regulatory environments. Additionally, there was a Q&A session where analysts asked about future projections, R&D investments, and the company's approach to sustainability and ESG (Environmental, Social, and Governance) goals.

Read the Full MSN Article at:
[ https://www.msn.com/en-us/money/companies/johnson-johnson-nyse-jnj-q4-2024-earnings-call-transcript/ar-AA1xJ3VP ]
Contributing Sources